Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects
about
Fluticasone at different doses for chronic asthma in adults and childrenFluticasone versus placebo for chronic asthma in adults and childrenFluticasone versus beclomethasone or budesonide for chronic asthma in adults and childrenFluticasone versus placebo for chronic asthma in adults and childrenFluticasone at different doses for chronic asthma in adults and childrenFluticasone versus beclomethasone or budesonide for chronic asthma in adults and childrenAdd-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive reviewInhaled CorticosteroidsThe role of inhaled corticosteroids in the management of cystic fibrosis.Survey of adrenal crisis associated with inhaled corticosteroids in the United KingdomDifficult asthma in children.Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthmaPlasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjectsPharmacokinetics and systemic effects of inhaled fluticasone propionate in chronic obstructive pulmonary disease.Plasma concentrations of inhaled corticosteroids in relation to airflow obstruction in asthma.The risk/benefit of inhaled corticosteroids in chronic obstructive pulmonary disease.Comparison of the effect of high-dose inhaled budesonide and fluticasone on adrenal function in patients with severe chronic obstructive pulmonary disease.Airway selectivity: an update of pharmacokinetic factors affecting local and systemic disposition of inhaled steroids.Topical Steroid Therapy for the Treatment of Eosinophilic Esophagitis (EoE): A Systematic Review and Meta-Analysis.Evidence-based selection of inhaled corticosteroid for treatment of chronic asthma.The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial.From inhaler to lung: clinical implications of the formulations of ciclesonide and other inhaled corticosteroids.Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone.Efficacy and safety of inhaled corticosteroids relative to fluticasone propionate: a systematic review of randomized controlled trials in asthma.Efficacy and safety of ciclesonide in patients with severe asthma: a 12-week, double-blind, randomized, parallel-group study with long-term (1-year) follow-up.Efficacy and Tolerability of an Inhaled Selective Glucocorticoid Receptor Modulator - AZD5423 - in Chronic Obstructive Pulmonary Disease Patients: Phase II Study Results.
P2860
Q24241300-7AA9E4CE-D87C-4F8E-B168-BD6B0ABEFA7EQ24241308-C6E2E46B-F142-42EE-8F75-A10B0A90974FQ24243570-A9A4D5C3-E3C4-45CC-8804-F7891381875DQ24245407-2B04548F-9EC6-4EB5-9347-90C22B5C85EBQ24246348-647B264F-5924-4557-B5F0-EF2AED9E3EF2Q24246921-D63F883D-EE6D-46A2-8147-DAA1517CD01EQ24794527-3CC1F2CF-027E-40AF-8820-7C9ABCFD8BDCQ33664193-842669CB-93F8-4F3A-8F59-9D83AF6D25BBQ34131911-D640869A-3979-4F17-926B-02C550B274EEQ34161394-DF6948A2-5A85-499C-83EB-91833372D464Q34905952-AC18AC3C-53BC-4B1C-B6E5-1923E81BC481Q35534837-3D09DEF5-03B5-440F-994B-CCB1055F9722Q35535742-5C6FEB67-56AD-4EDB-9125-55DE52B07C4DQ35825280-D1939708-EA13-4D42-B82B-CF142E24CAADQ35827816-7D951356-B166-4DFB-A99C-B121D0A37205Q36082007-34F1F142-400E-4C87-95D7-36FD542584FDQ36181507-F77DD51C-6E49-4833-B795-D6C398987FA2Q36478796-64C2B048-D2BA-424F-8514-A0D322A9537CQ36751852-E2DFDF68-5F1C-41E1-834D-7C3752ABC04EQ36761823-D344EECB-D74A-42F8-B78F-0F2131C36035Q37428235-66850A66-30B6-4B47-9356-F184F4DBA0F9Q38091676-15B4A43C-06EB-4F84-B2C8-59220D195F7FQ39783136-1FAACC7B-340F-4C2D-B74C-872B218FC4BCQ40104404-F659C2DD-F5A1-4D03-871B-5F02EFE810B9Q42854436-31D48FC1-F665-499A-8E7A-00B1DA73BA0DQ50886457-84A39B4A-0C70-4A10-8DA7-AB30E0065462
P2860
Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Comparison of the systemic eff ...... healthy and asthmatic subjects
@ast
Comparison of the systemic eff ...... healthy and asthmatic subjects
@en
Comparison of the systemic eff ...... healthy and asthmatic subjects
@nl
type
label
Comparison of the systemic eff ...... healthy and asthmatic subjects
@ast
Comparison of the systemic eff ...... healthy and asthmatic subjects
@en
Comparison of the systemic eff ...... healthy and asthmatic subjects
@nl
prefLabel
Comparison of the systemic eff ...... healthy and asthmatic subjects
@ast
Comparison of the systemic eff ...... healthy and asthmatic subjects
@en
Comparison of the systemic eff ...... healthy and asthmatic subjects
@nl
P2093
P2860
P356
P1433
P1476
Comparison of the systemic eff ...... healthy and asthmatic subjects
@en
P2093
A E Tattersfield
A Wisniewski
T W Harrison
P2860
P304
P356
10.1136/THORAX.56.3.186
P407
P577
2001-03-01T00:00:00Z